Skip to main content
Figure 2 | Proteome Science

Figure 2

From: Proteins related to lipoprotein profile were identified using a pharmaco-proteomic approach as markers for growth response to growth hormone (GH) treatment in short prepubertal children

Figure 2

Protein peaks at 1 year of treatment that were predictive of 2-year growth response. The figure shows the correlation between the observed delta height SDS 0--2 year (y-axis) and the predicted delta height SDS 0--2 year (x-axis), using the combined intensities of the predictors with M/Z values A) --17146 (Apo A-II), +8696 (Apo A-II), --9019 (Apo A-II), +4408 (Apo A-II) (r = 0.64, p = 0.017). B) +4470 (Apo A-II), --8767 (Apo A-II), --12872 (TTR), --12607 (SAA 4), +8875 (Apo A-II), +9425 (Apo C-III), --3160, --6857 (Apo C-I) (r = 0.47, p = 0.015). C) --4628, +4470 (Apo A-II), +8817 (Apo A-II), +4793, --17146 (Apo A-II), --12872 (TTR), --9019 (Apo A-II), +8875 (Apo A-II) (r = 0.38, p = 0.003) after 1 year of treatment in (A) GH-deficient children (GHD), (B) children with idiopathic short stature (ISS), and (C) the total group. A positive sign indicates a positive correlation with the outcome variable whereas a negative sign indicates a negative correlation with the outcome variable.

Back to article page

Proteome Science

ISSN: 1477-5956